Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinflunine Plus Capecitabine vs Capecitabine in Advanced Breast Cancer
NCT01953003Phase 3Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Sep 2013
- Primary completion
- Jul 2017
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of vinflunine in breast cancer, sponsored by Pierre Fabre Laboratories. Started Sep 2013; status: completed.
02
Drugs
vinflunine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01953003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01953003.